939376-61-1 Usage
Chemical structure
The compound consists of a pyridinyl group attached to a pyrrolidinol moiety.
Amino group
It has an amino group on the pyridinyl ring.
Chiral center
The compound has a chiral center on the pyrrolidinol, which gives it a specific configuration (S).
Biochemical applications
It can be used in various biochemical applications due to its potential for interacting with biological systems.
Medicinal applications
It has potential medicinal applications, although further studies are needed to fully understand its biological activity and potential benefits.
Therapeutic effects
Research suggests that 1-(5-AMINO-2-PYRIDINYL)-3-(S)-PYRROLIDINOL may have therapeutic effects in the treatment of certain conditions.
Further research
More studies are needed to fully understand the compound's biological activity, potential benefits, and its role in treating specific conditions.
Check Digit Verification of cas no
The CAS Registry Mumber 939376-61-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,3,9,3,7 and 6 respectively; the second part has 2 digits, 6 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 939376-61:
(8*9)+(7*3)+(6*9)+(5*3)+(4*7)+(3*6)+(2*6)+(1*1)=221
221 % 10 = 1
So 939376-61-1 is a valid CAS Registry Number.
939376-61-1Relevant articles and documents
SUBSTITUTED HETEROAROMATIC PYRAZOLE-CONTAINING CARBOXAMIDE AND UREA DERIVATIVES AS VANILLOID RECEPTOR LIGANDS
-
, (2013/03/26)
The invention relates to substituted heteroaromatic pyrazole-containing carboxamide and urea derivatives as vanilloid receptor ligands, to pharmaceutical compositions containing these compounds and also to these compounds for use in the treatment and/or prophylaxis of pain and further diseases and/or disorders.
Substituted Heteroaromatic Pyrazole-Containing Carboxamide and Urea Compounds as Vanilloid Receptor Ligands
-
, (2013/03/26)
Substituted heteroaromatic pyrazole-containing carboxamide and urea compounds as vanilloid receptor ligands, pharmaceutical compositions containing these compounds and also to a method of using these compounds for treating and/or inhibiting pain and further diseases and/or disorders.
Diacylglycerol acyltransferase inhibitors
-
Page/Page column 17, (2010/11/27)
Provided herein are compounds of the formula (I): as well as pharmaceutically acceptable salts thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical compositions containing them, are useful for the treatment of diseases such as, for example, obesity, type II diabetes mellitus and metabolic syndrome.
